Skip to main content

Search

7 result(s) for 'author#"Shuzo Matsushita"' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. The International AIDS Society convened the multi-stakeholder “Towards an HIV Cure” symposium in Kuala Lumpur, Malaysia in 2013 to address the significant research challenges posed by the search for a cure for...

    Authors: Damian FJ Purcell, Julian H Elliott, Anna-Laura Ross and John Frater

    Citation: Retrovirology 2013 10:134

    Content type: Commentary

    Published on:

  2. The genome of human immunodeficiency virus type 1 (HIV-1) is encapsulated in a core consisting of viral capsid proteins (CA). After viral entry, the HIV-1 core dissociates and releases the viral genome into th...

    Authors: Naoki Kishimoto, Ryosuke Okano, Ayano Akita, Satoshi Miura, Ayaka Irie, Nobutoki Takamune and Shogo Misumi

    Citation: Retrovirology 2021 18:30

    Content type: Research

    Published on:

  3. A protein exhibiting more than one biochemical function is termed a moonlighting protein. Glycolytic enzymes are typical moonlighting proteins, and these enzymes control the infection of various viruses. Previ...

    Authors: Naoki Kishimoto, Kengo Yamamoto, Nozomi Iga, Chie Kirihara, Towa Abe, Nobutoki Takamune and Shogo Misumi

    Citation: Retrovirology 2020 17:31

    Content type: Research

    Published on:

  4. Recent data suggest the importance of non-neutralizing antibodies (nnAbs) in the development of vaccines against HIV-1 because two types of nnAbs that recognize the coreceptor binding site (CoRBS) and the C1C2...

    Authors: Hasan Md Zahid, Takeo Kuwata, Shokichi Takahama, Yu Kaku, Shashwata Biswas, Kaho Matsumoto, Hirokazu Tamamura and Shuzo Matsushita

    Citation: Retrovirology 2021 18:23

    Content type: Research

    Published on:

  5. The CD4-induced (CD4i) epitopes in gp120 includes the co-receptor binding site, which are formed and exposed after interaction with CD4. Monoclonal antibodies (mAbs) to the CD4i epitopes exhibit limited neutra...

    Authors: Kazuki Tanaka, Takeo Kuwata, Muntasir Alam, Gilad Kaplan, Shokichi Takahama, Kristel Paola Ramirez Valdez, Anna Roitburd-Berman, Jonathan M. Gershoni and Shuzo Matsushita

    Citation: Retrovirology 2017 14:44

    Content type: Research

    Published on:

  6. HIV-1 typically develops resistance to any single antiretroviral agent. Combined anti-retroviral therapy to reduce drug-resistance development is necessary to control HIV-1 infection. Here, to assess the utili...

    Authors: Muntasir Alam, Takeo Kuwata, Kazuya Shimura, Masaru Yokoyama, Kristel Paola Ramirez Valdez, Kazuki Tanaka, Yasuhiro Maruta, Shinya Oishi, Nobutaka Fujii, Hironori Sato, Masao Matsuoka and Shuzo Matsushita

    Citation: Retrovirology 2016 13:70

    Content type: Research

    Published on: